Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
Yatharth Hospit.Q1 FY27Healthcare Services
Home/Stocks/Yatharth Hospit./Q1 FY27

Yatharth Hospit. Q1 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹925P/E: 45.5Market Cap: ₹8.2K CrSector: Healthcare Services

Management growth scorecard

Revenue

N/A

Margin

N/A

Fundraise

N/A

Order

N/A

Capex

N/A

0 of 0 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

  • →FY27 revenue growth is expected to surpass last year's 37% YoY growth.
  • →ARPOB (Average Revenue Per Occupied Bed) growth guidance for FY27 is around 9-10% YoY.
  • →Newer hospitals have ARPOB around INR 40,000-50,000, expected to grow 8-10% annually.
  • →EBITDA margin expected upwards of 24% for FY27, with new hospitals projected to reach 25-27% EBITDA margins within 2 years.
  • →Capacity expansion targets 3,200 beds operational soon, with a goal to reach 5,000 beds within approximately 2.5 years, faster than the originally planned 3 years.
  • →Growth focus remains on North India clusters (Delhi NCR, UP, Haryana, Rajasthan) with potential new metro clusters.
  • →Expansion includes greenfield, brownfield, and acquisitions, aiming to add at least one new hospital per year.
  • →Overall growth momentum expected to be sustained in coming years.

Margin guidance

  • →Revenue growth for FY27 is expected to surpass last year's 37% Y-o-Y growth, with sustained momentum ahead.
  • →EBITDA margin guidance for FY27 is around 24% to 25%, with expectations of maintaining or slightly improving this level in coming years.
  • →Newer hospitals currently around breakeven are targeted to achieve EBITDA margins of 25-27% within two years.
  • →ARPOB (Average Revenue Per Occupied Bed) is projected to grow at 8-10% annually over the next 2-3 years, with newer hospitals already clocking INR 40,000-50,000 ARPOB.
  • →PAT margins have seen short-term pressure due to high capex and interest costs but expected to stabilize and improve as new assets mature and capex normalizes.
  • →Management confident of achieving target bed capacity of 5,000 beds earlier than planned, supporting higher scale and earnings growth.
  • →Debt levels are manageable with sufficient internal accruals to fund expansions, supporting sustainable profit growth.

3 more insights locked — sign up free to unlock

Fundraise plans

  • →The company currently has a debt of around INR 300 crores, increased from INR 210 crores mainly due to INR 80 crores taken for acquisitions.
  • →Going forward, they plan to utilize internal accruals to fund acquisitions and maintenance/growth capex in existing hospitals.
  • →They do not intend to take fresh loans in the near term, so interest costs are expected to remain stable (Q1 interest cost INR 6.6 crores).
  • →Management is comfortable with current debt levels, having capacity to take up to 2x trailing EBITDA at the group level.
  • →No explicit mention of upcoming equity fundraising; focus is on using internal accruals and manageable debt.
  • →The company is well-positioned with cash, debt capacity, and accruals to fund the remaining capex for adding 1,800 beds.

Order book

The transcript does not explicitly mention current or expected orderbook or pending orders for Yatharth Hospitals and Trauma Care Services Limited. However, key related points include: - The company is actively progressing on brownfield expansions at Noida Extension and Greater Noida, expecting 450 additional beds operational in about 15-18 months. - The Gurugram facility with 250 beds is expected to be live by Q1 of the next financial year (FY28). - The roadmap targets doubling capacity from current 3,200 beds to 5,000 beds, likely earlier than 3 years, primarily within North India clusters. - Significant capex including acquisition of Gurgaon and oncology equipment indicates ongoing investment commitments. - Discussions mention no fresh loans planned for the near term, indicating order execution is ongoing based on existing financing. No direct reference to orderbooks or pending order values was provided in the transcript.

Capex plans

  • →Capex per bed is expected to be around INR 75-80 lakhs, including greenfield, brownfield, and acquisitions.
  • →The Gurugram facility construction is progressing and expected to go live by Q1 of the next fiscal year.
  • →Brownfield expansions planned at Noida Extension and Greater Noida, with capacity additions expected in 15-18 months.
  • →Total bed capacity to reach over 3,200 beds soon, aiming for 5,000 beds within the next 2.5-3 years, possibly earlier.
  • →No significant fresh loans planned; capex funded through internal accruals and existing debt (currently around INR 300 crores).
  • →Focus on acquisitions of premium assets with high ARPOB potential in cities where they operate.
  • →Oncology equipment investments made recently for Faridabad and Model Town hospitals, contributing to capex.
  • →ESOP schemes introduced to retain talent, supporting strategic human capital investment.

How does Yatharth Hospit. rank vs peers in Healthcare Services?

Pro feature
1Yatharth Hospit.
2Healthcare Services Company A
Rev 1Mar 2
3Healthcare Services Company B
Rev 2Mar 1
4Healthcare Services Company C
Rev 2Mar 3

See full Healthcare Services sector rankings

How does Yatharth Hospit. rank in Healthcare Services?

Compare Yatharth Hospit. against every Healthcare Services company (Q1 FY27) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Related research

Read the full Q1 FY27 earnings insight — Yatharth Hospit.

Other quarters — Yatharth Hospit.

Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24

Healthcare Services peers

Apollo Hospitals Enterprise Ltd · Q4 FY26Fortis Health. · Q1 FY27Syngene Intl. · Q4 FY26Dr Lal Pathlabs · Q1 FY27Narayana Hrudaya · Q1 FY27
Yatharth Hospit. full stock analysisHealthcare Services sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What Yatharth Hospit.'s management said in earlier quarters

  • Q1 FY27 earnings call analysis →
  • Q3 FY26 earnings call analysis →
  • Q1 FY26 earnings call analysis →
  • Q4 FY25 earnings call analysis →

Others in Healthcare Services this season

  • Aster DM Quality (Q3 FY26)

    Mature hospitals show steady revenue growth of 14%, hospitals 3-7 years old growing at 10%, and new assets under 3 years growing at 19%. Key concall takeaways…

  • Chandan Healthcare Ltd (Q3 FY26)

    The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…

  • Apollo Hospitals Enterprise Ltd (Q4 FY26)

    30% growth currently driven by top 5 markets; expansion planned into new markets. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY26 earnings…

  • Health X Platform Ltd (Q4 FY26)

    Northeast operations growing 50%+ year-on-year and Northern India 25–30%, with plans for 5–7% market share in 2-3 years (Page 10). Key concall takeaways from…

Compare:vs Apollo Hospitals Enterprise Ltdvs Max Healthcarevs Fortis Health.